Sign in

CIK 0001534969

  • Non-accelerated filer
  • Smaller reporting company
  • Emerging growth company

SERA PROGNOSTICS, INC.

Sign in to watch
Ticker
SERA
Exchange
Nasdaq
Industry
Services-Medical Laboratories
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
261911522
Phone
+1 801-990-0520
Business address
2749 E. PARLEYS WAY, SUITE 200, SALT LAKE CITY, UT, 84109
Former names
SERA PROGNOSTICS, INC.
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$79,563
in 6 filings

Net −$79,563. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Date Insider Transaction Shares Price Value Owned after
2026-07-10 Capone Mark Christopher Director Grant or award +42,404 42,404
2026-07-10 Capone Mark Christopher Director Grant or award +1,975 44,379
2026-07-10 Capone Mark Christopher Director Grant or award · Stock Option (right to buy) +62,766 62,766
2026-07-10 Capone Mark Christopher Director Grant or award · Stock Option (right to buy) +3,037 3,037

Page 1 of 1 · 4 trades